You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Baxter
Express Scripts
Merck
McKinsey

Last Updated: March 4, 2021

DrugPatentWatch Database Preview

Litigation Details for Acura Pharmaceuticals Inc. v. Watson Laboratories Inc.-Florida (D. Del. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Acura Pharmaceuticals Inc. v. Watson Laboratories Inc.-Florida
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Acura Pharmaceuticals Inc. v. Watson Laboratories Inc.-Florida (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-10-31 1 Complaint corresponding to the expiration date of the U.S. Patent No. 7,201,920, granted by the USPTO pursuant to 35 U.S.C… current owner of United States Patent No. 7,510,726 (“the ’726 patent”). 2. On information and belief…, 2009). 12. This patent infringement action arises under the United States Patent Laws, Title 35 U.S.C…and 1400(b). COUNT I FOR PATENT INFRINGEMENT (Infringement of the ’726 Patent Under 35 U.S.C. § 271(e)…the United States Patent and Trademark Office (“USPTO”) on March 31, 2009. The patent claims, inter alia External link to document
2013-01-02 10 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,510,726 B2. (Attachments: #…2012 2 January 2013 1:12-cv-01374 830 Patent None District Court, D. Delaware External link to document
2012-10-31 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,510,726 B2;. (dmp, ) (Entered…2012 2 January 2013 1:12-cv-01374 830 Patent None District Court, D. Delaware External link to document
2013-01-01 9 Notice (Other) of U.S. Patent No. 7,510,726 (“the ’726 patent”), 7,201,920 (“the ’920 patent”), and 7,981,439…of the ’726 patent; and 4. WHEREAS subsequent to Acura’s complaint for patent infringement… 7,981,439 (“the ’439 patent”) were invalid, unenforceable, and/or not infringed by Watson…until the expiration of the ’726, ’920, and ’439 patents, thereby removing the case or …2012 2 January 2013 1:12-cv-01374 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Mallinckrodt
Merck
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.